JPMorgan sees Torrent’s India operations as a primary growth engine, backed by sustained momentum in its core therapeutic ...

KKR’s stake is worth approximately ₹13,400 crore considering the J B Pharma stock’s closing price of ₹1,802.9 per share on ...

According to JPMorgan, the upgrade was driven by strong growth momentum in India, which is expected to continue.

Torrent Pharma is in advanced talks to acquire JB Chemicals from KKR, a deal that could trigger a mandatory open offer under ...

Ahmedabad-based Torrent Pharma has revived talks with PE major KKR to buy its stake in Mumbai-based JB Chemicals & ...

Torrent Pharma, currently seventh in India, is aimingto break into the top three drugmakers within five years through ...

Looking ahead, select buzzing stocks like Bharat Electronics Ltd (BEL), Torrent Pharmaceuticals Ltd and Techno Electric & ...

Torrent Pharma is in advanced talks with KKR to acquire JB Chemicals and Pharmaceuticals, reviving discussions from last year. The deal involves Torrent acquiring KKR's 47.84% stake and launching an ...

Torrent Pharmaceuticals is in an advanced stage of talks to acquire a major stake in JB Chemicals. The company is eyeing a $2 ...

With a surge in US patent expiries and a $180 bn global LoE opportunity by 2035, Indian drugmakers are set to climb the value ...

HCL Tech: The IT major has expanded its partnership with Salesforce and launched new services to support adoption of ...